Louisiana believes it paid prices that were up to 6,000% higher than whole sale prices on drugs for their Medicaid program. Between 1991 and 2000, they paid 18 drug makers approximately $850 million. Twenty-seven other states have filed similar charges against the drug companies. Read the full article at Pharmalot.
About Us
Health Care Insights - From Policy to Practice is the trusted source for news and commentary from the nation's leading Health Care Events such as Medicaid Drug Rebate Program Summit (MDRP), Medicaid Managed Care Congress (MMCC), FDA/CMS to inform Health Plans and Pharmaceutical Manufacturers on the latest developments on Medicare, Medicaid Managed Care, Government Programs, and Health Insurance Exchanges.
Topics we cover include reform, best business practices, the latest innovations, and novel payment models.
Subscribe
Blog Archive
-
▼
2010
(111)
-
▼
November
(7)
- Medicare cuts delayed once again
- Government Programs 2011: Brochure now available f...
- Preventing business if drug companies executives a...
- The Medicare Congress Podcast: John Gorman of Gorm...
- My Medicare Advocate helps seniors navigate Medica...
- Louisiana sues drug companies for fraud
- AMA on the current elections
-
▼
November
(7)
No comments:
Post a Comment